APA
El Kassas M., Funk A. L., Salaheldin M., Shimakawa Y., Eltabbakh M., Jean K., El Tahan A., Sweedy A. T., Afify S., Youssef N. F., Esmat G. & Fontanet A. (20181015). Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis. : Journal of viral hepatitis.
Chicago
El Kassas M, Funk A L, Salaheldin M, Shimakawa Y, Eltabbakh M, Jean K, El Tahan A, Sweedy A T, Afify S, Youssef N F, Esmat G and Fontanet A. 20181015. Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis. : Journal of viral hepatitis.
Harvard
El Kassas M., Funk A. L., Salaheldin M., Shimakawa Y., Eltabbakh M., Jean K., El Tahan A., Sweedy A. T., Afify S., Youssef N. F., Esmat G. and Fontanet A. (20181015). Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis. : Journal of viral hepatitis.
MLA
El Kassas M, Funk A L, Salaheldin M, Shimakawa Y, Eltabbakh M, Jean K, El Tahan A, Sweedy A T, Afify S, Youssef N F, Esmat G and Fontanet A. Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis. : Journal of viral hepatitis. 20181015.